Tertiary Nav - Press Releases Press ReleasesMedia Statements Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 10/20/10 Data From AVI BioPharma's RNA-Based Influenza and Dengue Virus Programs to Be Presented at 48th Annual Meeting of Infectious Diseases Society of America 10/20/10 AVI BioPharma to Present Data on RNA-Based Duchenne Muscular Dystrophy and Influenza Drug Candidates at 6th Annual Meeting of the Oligonucleotide Therapeutics Society 10/19/10 AVI BioPharma to Present at the BioCentury NewsMakers in the Biotech Industry Conference 10/15/10 AVI BioPharma's Investigational Drug Candidate AVI-4658 Demonstrates Broadly Favorable Profile of Safety and Tolerability, New Dystrophin Expression, Stable Clinical Performance and Inflammatory Modulation in the Treatment of Duchenne Muscular Dystrophy 10/11/10 AVI BioPharma Announces Data Presentations for RNA-Based Duchenne Muscular Dystrophy Drug Candidate at 15th International Congress of the World Muscle Society 9/22/10 AVI BioPharma to Present at JMP Securities Healthcare Conference 9/14/10 AVI BioPharma to Present at UBS Global Life Sciences Conference 9/9/10 AVI BioPharma Announces Presentations at 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting 9/8/10 AVI BioPharma Issued U.S. Patent Providing Key Coverage of RNA-Based Therapeutics as Antibacterial Agents 9/7/10 AVI BioPharma to Present at Rodman & Renshaw Annual Global Investment Conference Pagination First page « first Previous page ‹ previous … Page 58 Page 59 Page 60 Page 61 Current page 62 Page 63 Page 64 Page 65 Page 66 … Next page next › Last page last » Displaying 611 - 620 of 816 Toolkit Print Page | Email Alerts | RSS Feeds | Contacts
Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 10/20/10 Data From AVI BioPharma's RNA-Based Influenza and Dengue Virus Programs to Be Presented at 48th Annual Meeting of Infectious Diseases Society of America 10/20/10 AVI BioPharma to Present Data on RNA-Based Duchenne Muscular Dystrophy and Influenza Drug Candidates at 6th Annual Meeting of the Oligonucleotide Therapeutics Society 10/19/10 AVI BioPharma to Present at the BioCentury NewsMakers in the Biotech Industry Conference 10/15/10 AVI BioPharma's Investigational Drug Candidate AVI-4658 Demonstrates Broadly Favorable Profile of Safety and Tolerability, New Dystrophin Expression, Stable Clinical Performance and Inflammatory Modulation in the Treatment of Duchenne Muscular Dystrophy 10/11/10 AVI BioPharma Announces Data Presentations for RNA-Based Duchenne Muscular Dystrophy Drug Candidate at 15th International Congress of the World Muscle Society 9/22/10 AVI BioPharma to Present at JMP Securities Healthcare Conference 9/14/10 AVI BioPharma to Present at UBS Global Life Sciences Conference 9/9/10 AVI BioPharma Announces Presentations at 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting 9/8/10 AVI BioPharma Issued U.S. Patent Providing Key Coverage of RNA-Based Therapeutics as Antibacterial Agents 9/7/10 AVI BioPharma to Present at Rodman & Renshaw Annual Global Investment Conference Pagination First page « first Previous page ‹ previous … Page 58 Page 59 Page 60 Page 61 Current page 62 Page 63 Page 64 Page 65 Page 66 … Next page next › Last page last » Displaying 611 - 620 of 816